COVID-19 pandemic in Manipur
Overview of the COVID-19 pandemic in Manipur
The COVID-19 pandemic in Manipur is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first case in the Indian state of Manipur was reported on 24 March 2020.
Background[edit]
The COVID-19 pandemic was confirmed to have reached India on 30 January 2020, originating from China. The first case in Manipur was a student who had returned from the United Kingdom.
Timeline[edit]
2020[edit]
On 24 March 2020, Manipur reported its first COVID-19 case. The patient was a 23-year-old woman who had returned from the UK. The state government quickly implemented measures to contain the spread, including lockdowns and travel restrictions.
In April 2020, the state reported its second case, a 65-year-old man who had attended a religious congregation in Delhi. This led to increased testing and contact tracing efforts.
2021[edit]

In 2021, the state faced challenges with the second wave of COVID-19, which saw a significant increase in cases and fatalities. The government ramped up vaccination efforts and imposed stricter lockdown measures to curb the spread.
Government Response[edit]
The government of Manipur implemented several measures to control the pandemic, including:
- Lockdowns and Curfews: Periodic lockdowns and curfews were imposed to limit movement and gatherings.
- Testing and Quarantine: Extensive testing and mandatory quarantine for travelers were enforced.
- Vaccination Campaigns: The state launched vaccination drives to immunize the population against COVID-19.
Impact[edit]
The pandemic had a significant impact on the economy and daily life in Manipur. Educational institutions were closed, and many businesses faced disruptions. The healthcare system was strained, but efforts were made to increase capacity and resources.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian